Both in Biotechnology
Silexion Therapeutics vs Curis
Over the past year SLXN returned −99.1% and CRIS returned −97.5%; their daily moves had a correlation of 0.01.
SLXN −99.1% CRIS −97.5%Growth of $1, one year, split-adjusted
| Metric | SLXN | CRIS |
|---|---|---|
| Price | $0.3184 | $0.8290 |
| Market cap | $1.8M | $2.0M |
| Today | +28.18% | −0.29% |
| 1 month | −12.2% | −44.4% |
| 6 months | −97.3% | −91.9% |
| Year to date | −98.3% | −95.8% |
| 1 year | −99.1% | −97.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 0.5× |
| Net cash | — | $5.1M |
| Dividend yield | — | — |
| Volatility (60d) | 248.9% | 126.5% |
| Short % of float | 5.1% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).